Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

Share Price Information for Science Sprt (SIS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.75
Bid: 18.50
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 0.50 (2.703%)
Open: 18.75
High: 18.75
Low: 18.75
Prev. Close: 18.75
SIS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

22 Mar 2018 07:00

RNS Number : 5325I
Science in Sport PLC
22 March 2018
 

22 March 2018

SCIENCE IN SPORT PLC

("SiS" or the "Company")

 

ISSUE OF EQUITY AND TOTAL VOTING RIGHTS

Science in Sport plc (AIM: SIS), a leading sports nutrition company that develops, manufactures and markets sports nutrition produces for professional athletes and sports enthusiasts announces that it has applied for 136,612 New Ordinary Shares of 10 pence each ("New Ordinary Shares") to be admitted to trading on AIM ("Admission").

 

The New Ordinary Shares are being issued as consideration related to sponsorship services. It is expected that dealings in the New Ordinary Shares will commence at 8.00 a.m. on 27 March 2018.

Following admission, the Company will have 67,397,674 Ordinary Shares of 10 pence each ("Ordinary Shares") outstanding. The figure of 67,397,674 Ordinary Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

For further information:

Science in Sport PLC
+44 (0) 20 7400 3700
Stephen Moon, CEO
Elizabeth Lake, Finance Director
 
Cenkos Securities - NOMAD and Broker
 
+44 (0) 20 7397 8900
Bobbie Hilliam

Yellow Jersey PR - Financial PR

Felicity Winkles
+44 (0) 7748 843 871
Harriet Jackson
+44 (0) 7544 275 882

Notes for editors

About Science in Sport plc

Science in Sport plc is a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts. SiS is a strong brand in the elite athlete community - in the 2016 Rio Olympics, 34 medal-winning athletes or teams used SiS products (compared with 24 in 2012).

The SiS core product ranges include: SiS GO, comprising energy powders, isotonic gels, energy bars and shots; SiS REGO, including protein-based recovery powders; SiS Protein, products specifically designed to contribute to athletes' lean muscle mass growth and maintenance; SiS Supplements, comprising BCAA Perform, Creatine, Beta Alanine and L Glutamine; SiS Athlete Health, vitamins and supplements range designed to support and maintain immune function, digestive health and bone health. SiS products are sold in a range of retail channels, including specialist sport retailers, major grocers, high street retailers and e-commerce websites.

SiS is currently the official sports nutrition partner to professional cycling organisations Team SKY, British Cycling, Cycling Australia and USA Cycling. SiS is also a partner to British Triathlon & USA Triathlon. Along with supplying over 40 professional English & Scottish League football teams, SiS is Sports Nutrition Partner to the world's most popular football club, Manchester United FC. In addition, Olympians Sir Chris Hoy MBE, Mark Cavendish MBE and Adam Peaty MBE are Brand Ambassadors.

SiS was founded in 1992 and is headquartered in Hatton Garden, London. Its manufacturing facility is in Nelson, Lancashire.

SiS shares are traded on the AIM market of the London Stock Exchange under the ticker symbol SIS.

For further information, please visit www.scienceinsport.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEXFLLLVXFLBBF
Date   Source Headline
9th Oct 20142:45 pmRNSNotification of Major Interest in Shares
1st Oct 20141:15 pmRNSDirector's Dealing
30th Sep 201411:00 amRNSResult of AGM
30th Sep 20147:00 amRNSAGM Statement and Half Year Trading Update
19th Aug 20145:01 pmRNSNotification of Major Interest in Shares
11th Aug 20142:50 pmRNSIssue of Equity
22nd Jul 20147:00 amRNSGrant of Options
4th Jul 20147:00 amRNSAnnual Report and Notice of AGM
1st Jul 20147:00 amRNSTotal Voting Rights
26th Jun 20147:00 amRNSAppointment of Finance Director
26th Jun 20147:00 amRNSPreliminary Results
17th Jun 20144:22 pmRNSNotification of Major Interest in Shares
14th May 20147:00 amRNSLaunches Mobile Website
8th May 20147:00 amRNSNotification of Preliminary Results
28th Apr 20147:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
17th Apr 20143:07 pmRNSNotification of Major Interest in Shares
17th Apr 20147:00 amRNSNotification of Major Interest in Shares
9th Apr 20147:00 amRNSFull Year Trading Update and Placing
3rd Mar 20147:00 amRNSOpens Head Office in London
26th Feb 20144:30 pmRNSNotification of Major Interest in Shares
17th Dec 20137:00 amRNSSigns Distribution Agreement with Shimano
4th Dec 20137:00 amRNSInterim Results
28th Nov 20137:00 amRNSSigns Asia Pacific Distribution Agreement
18th Nov 20133:09 pmRNSNotification of Major Interest in Shares
11th Nov 20132:21 pmRNSNotification of Major Interest in Shares
30th Oct 20137:00 amRNSNotification of Half Year Results
30th Sep 20137:00 amRNSHalf Year Trading Update
26th Sep 20137:00 amRNSAppoints Mark Cavendish as Elite Sports Consultant
30th Aug 201311:22 amRNSNotification of Major Interest in Shares
23rd Aug 20133:07 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
20th Aug 201311:08 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
9th Aug 20137:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.